Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Suchitra Kumari Panigrahy, Renu Bhatt & Awanish Kumar. (2017) Reactive oxygen species: sources, consequences and targeted therapy in type 2 diabetes. Journal of Drug Targeting 25:2, pages 93-101.
Read now
Read now
Ahmed M Abu El-Asrar, Hani S Al-Mezaine & Mohammad Shamsul Ola. (2009) Pathophysiology and management of diabetic retinopathy. Expert Review of Ophthalmology 4:6, pages 627-647.
Read now
Read now
Articles from other publishers (20)
Priyanka Bhandu, Himanshu Verma, Manmeet Singh, Manoj Kumar, Gera Narendra, Shalki Choudhary, Pankaj Kumar Singh & Om Silakari. (2022) Rational designing of quinazolin-4(3H)-one based ALR2 inhibitors: Synthesis and biological evaluation. Journal of Molecular Structure 1270, pages 133825.
Crossref
Crossref
Bhoomika Sherkhane, Anil Kumar Kalvala, Vijay Kumar Arruri, Dharmendra kumar Khatri & Shashi Bala Singh. (2022) Renoprotective potential of myo‐inositol on diabetic kidney disease: Focus on the role of the PINK1/Parkin pathway and mitophagy receptors. Journal of Biochemical and Molecular Toxicology.
Crossref
Crossref
Aqeel Imran, Muhammad Tariq Shehzad, Taha al Adhami, Khondaker Miraz Rahman, Dilawar Hussain, Rima D. Alharthy, Zahid Shafiq & Jamshed Iqbal. (2021) Development of coumarin-thiosemicarbazone hybrids as aldose reductase inhibitors: Biological assays, molecular docking, simulation studies and ADME evaluation. Bioorganic Chemistry 115, pages 105164.
Crossref
Crossref
Deep Shikha Sharma, Sachin Kumar Singh, Divya Thakur, Arya K.R, Rubiya Khursheed & Sheetu Wadhwa. (2020) Current Strategies and Future Perspective for the Effective Treatment of Diabetic Retinopathy. Current Drug Therapy 15:4, pages 299-311.
Crossref
Crossref
Yanni Zhu & Yanjuan Sheng. (2020) Sustained delivery of epalrestat to the retina using PEGylated solid lipid nanoparticles laden contact lens. International Journal of Pharmaceutics 587, pages 119688.
Crossref
Crossref
Nabeela Dulull, Faith Kwa, Narin Osman, Uma Rai, Bilal Shaikh & Thilini R. Thrimawithana. (2019) Recent advances in the management of diabetic retinopathy. Drug Discovery Today 24:8, pages 1499-1509.
Crossref
Crossref
Muhammad Tariq Shehzad, Aqeel Imran, Guy Sedar Singor Njateng, Abdul Hameed, Muhammad Islam, Mariya al-Rashida, Maliha Uroos, Asnuzilawati Asari, Zahid Shafiq & Jamshed Iqbal. (2019) Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study. Bioorganic Chemistry 87, pages 857-866.
Crossref
Crossref
Francesco Bandello, Rosangela Lattanzio, Emanuela Aragona, Alessandro Marchese, Giuseppe Querques & Ilaria Zucchiatti. 2019. Clinical Strategies in the Management of Diabetic Retinopathy. Clinical Strategies in the Management of Diabetic Retinopathy
21
95
.
Lei Lu, Ying Jiang, Ravindran Jaganathan & Yanli Hao. (2018) Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review. Journal of Ophthalmology 2018, pages 1-13.
Crossref
Crossref
Aamer Saeed, Yildiz Tehseen, Hummera Rafique, Norbert Furtmann, Jürgen Bajorath, Ulrich Flörke & Jamshed Iqbal. (2014) Benzothiazolyl substituted iminothiazolidinones and benzamido-oxothiazolidines as potent and partly selective aldose reductase inhibitors. Med. Chem. Commun. 5:9, pages 1371-1380.
Crossref
Crossref
Francesco Bandello, Rosangela Lattanzio, Ilaria Zucchiatti & Giuseppe Petruzzi. 2014. Clinical Strategies in the Management of Diabetic Retinopathy. Clinical Strategies in the Management of Diabetic Retinopathy
19
63
.
Ross Milne & Seymour Brownstein. (2011) Advanced glycation end products and diabetic retinopathy. Amino Acids 44:6, pages 1397-1407.
Crossref
Crossref
Mohammad Shamsul Ola. (2013) Novel drugs and their targets in the potential treatment of diabetic retinopathy. Medical Science Monitor 19, pages 300-308.
Crossref
Crossref
Yao-Yuan HsiehYu-Chuen HuangChi-Chen ChangYu-Kuo WangWen-Hsin LinFuu-Jen Tsai. (2012) Chromosome 15q21-22–Related Polymorphisms and Haplotypes Are Associated with Susceptibility to Type-2 Diabetic Nonproliferative Retinopathy. Genetic Testing and Molecular Biomarkers 16:5, pages 442-448.
Crossref
Crossref
E. J. Verspohl. (2012) Novel Pharmacological Approaches to the Treatment of Type 2 Diabetes. Pharmacological Reviews 64:2, pages 188-237.
Crossref
Crossref
Shani Golan & Anat Lowenstein. (2012) New developments in the treatment of diabetic macular edema: latest clinical evidence. Clinical Investigation 2:1, pages 89-105.
Crossref
Crossref
T. M. Curtis, R. Hamilton, P.-H. Yong, C. M. McVicar, A. Berner, R. Pringle, K. Uchida, R. Nagai, S. Brockbank & A. W. Stitt. (2010) Müller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products. Diabetologia 54:3, pages 690-698.
Crossref
Crossref
Francesco Boscia. (2010) Current Approaches to the Management of Diabetic Retinopathy and Diabetic Macular Oedema. Drugs 70:16, pages 2171-2200.
Crossref
Crossref
Ning Cheung, Paul Mitchell & Tien Yin Wong. (2010) Diabetic retinopathy. The Lancet 376:9735, pages 124-136.
Crossref
Crossref
. (2010) Current World Literature. Current Opinion in Ophthalmology 21:3, pages 239-246.
Crossref
Crossref